Clinical Education Alliance

Clinical Education Alliance

Drezner established the Alliance in 2014, consolidating a portfolio of existing independent education properties into a single physician-education delivery system serving specialties from oncology to infectious disease. The model emerged outside the traditional publishing or CME bureaucracy, prioritizing rapid-deployment digital tools that sponsor companies need to translate complex clinical trial data for time-pressured prescribers. Through its main platform Clinical Options, the Alliance deploys live symposia, virtual conferences, on-demand modules, and custom advisory boards. Confirmed therapeutic coverage spans HIV, hepatitis C, multiple sclerosis, schizophrenia, breast and lung cancers, and COVID-19 treatment regimens. It serves global pharmaceutical sponsors including Gilead, Merck, and Bristol Myers Squibb, combining digital reach with live speaker bureau management — a hybrid that sponsors rely on to shift prescribing behavior post-FDA approval. The privately held Reston, Virginia firm operates several branded education platforms: Clinical Options, Practicing Clinicians Exchange, the France Foundation, and MLI. In May 2023 it integrated MCM Education and DKBmed into its alliance portfolio, deepening its conference and video production capabilities. CEO Drezner acquired the individual properties from 2005 onward and architected the convergence under a single operating structure during the COVID-19 era, when virtual education demand accelerated permanently. Structurally the Alliance occupies an interstitial space between contract sales organizations and academic continuing education — it does not accredit physician hours directly, but produces the scientific content that accredited bodies distribute. That boundary position protects its content license from the Sunshine Act reporting requirements applied to speaker fees, a regulatory distinction that makes its platform logistically seamless for pharmaceutical medical-affairs budgets.